Abstract:Background The incidence of invasive candidiasis is increasing worldwide. However, the epidemiology, antifungal susceptibility, and virulence of Candida spp. in most hospitals remain unclear. This study aimed to evaluate invasive candidiasis in a tertiary care hospital in Nanchang City, China. Methods MALDI-TOF MS and 18S rDNA ITS sequencing were used to identify Candida strains. Randomly amplified polymorphic DNA analysis was used for molecular typing; biofilm production, caseinase, and hemolysin activities were used to evaluate virulence. The SensititreTM YeastOne YO10 panel was used to examine antifungal susceptibility. Mutations in ERG11 and the hotspot regions of FKS1 of drug-resistant strains were sequenced to evaluate the possible mechanisms of antifungal resistance. Results We obtained 110 Candida strains, which included 40 Candida albicans (36.36%), 37 C. parapsilosis (33.64%), 21 C. tropicalis (19.09%), 9 C. glabrata (8.18%), 2 C. rugose (1.82%), and 1 C. haemulonii (0.91%) isolates. At a limiting point of 0.80, C . albicans isolates could be grouped into five clusters, C . parapsilosis and C . tropicalis isolates into seven clusters, and C . glabrata isolates into only one cluster comprising six strains by RAPD typing. Antifungal susceptibility testing revealed that the isolates showed the greatest overall resistance against fluconazole (6.36%), followed by voriconazole (4.55%). All C . albicans and C . parapsilosis isolates exhibited 100% susceptibility to echinocandins (i.e., anidulafungin, caspofungin, and micafungin), whereas one C . glabrata strain was resistant to echinocandins. The most common amino acid substitutions noted in our study was 132aa (Y132H, Y132F) in the azole-resistant strains. No missense mutation was identified in the hotpot regions of FKS1 . Comparison of the selected virulence factors detectable in a laboratory environment, such as biofilm, caseinase, and hemolysin production, revealed that most Candida isolates were caseinase and hemolysin producers with a strong activity (Pz < 0.69). Furthermore, C. parapsilosis had greater total biofilm biomass (average Abs 620 = 0.712) than C. albicans (average Abs 620 = 0.214, p < 0.01) or C. tropicalis (average Abs 620 = 0.450, p < 0.05), although all C. glabrata strains were either low- or no-biofilm producers. The virulence level of the isolates from different specimen sources or clusters showed no obvious correlation. Interesting, 75% of the C. albicans from cluster F demonstrated azole resistance, whereas two azole-resistant C. tropicalis strains belonged to the cluster Y. Conclusion This study provides vital information regarding the epidemiology, pathogenicity, and antifungal susceptibility of Candida spp. in patients admitted to Nanchang City Hospital.

Epidemiology and drug-resistance analysis of nosocomial infection of Candida glabrata

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: an Update from the CHIF-NET Study

Molecular Epidemiology and Antifungal Susceptibility of Candida Glabrata in China (august 2009 to July 2014): A Multi-Center Study.

Drug resistance and genotypes of oral Candida albicans and expressions of drug-resistant genes of oral Candida albicans

Species identification and antibiotic resistance analysis of Candida clinical isolates

Genotypic Diversity And Epidemiology Of High-Level Gentamicin Resistant Enterococcus In A Chinese Hospital

Genotyping of Candida albicans based on 25S rDNA and its relationship to drug susceptibility

Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of Candida Isolates Causing Invasive Infection in a Tertiary Care Teaching Hospital

The study of multilocus sequence typing in Candida tropicalis

Clinical Distribution and Drug Resistance Analysis of 978 Clinical Fungus Strains

Genotyping and antifungal susceptibility analysis of Candida albicans isolates

Genetic and Phenotypic Characterization of Candida Albicans Strains Isolated from Infectious Disease Patients in Shanghai.

Molecular identification, antifungal susceptibility, and resistance mechanisms of pathogenic yeasts from the China antifungal resistance surveillance trial (CARST-fungi) study

Study on drug resistance of fungi isolated from infected patients in hospital

Species identification and antifungal susceptibility of 128 strains of yeast fungi

Association of multilocus sequence typing, MSH2 gene mutations, and antifungal resistance in Candida glabrata: implications for clinical outcomes in Chinese hospitals

Prevalence and Antifungal Susceptibility of Pathogenic Yeasts in China: A 10-Year Retrospective Study in a Teaching Hospital

Antifungal Susceptibilities of Candida Glabrata Species Complex, Candida Krusei, Candida Parapsilosis Species Complex and Candida Tropicalis Causing Invasive Candidiasis in China: 3 Year National Surveillance

In Vitro Antidrug Susceptibility Testing of Candida Species Isolated from Aseptic Body Fluids

Multilocus Sequence Typing of Candida Tropicalis Shows Clonal Cluster Enrichment in Azole-Resistant Isolates from Patients in Shanghai, China

In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.